Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

1.

Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori.

Yakoob J, Abbas Z, Usman MW, Awan S, Naz S, Jafri F, Hamid S, Jafri W.

Microb Drug Resist. 2014 Aug;20(4):305-9. doi: 10.1089/mdr.2013.0086. Epub 2013 Jul 11.

PMID:
23844851
2.

Evaluation of a four-drug, three-antibiotic, nonbismuth-containing "concomitant" therapy as first-line Helicobacter pylori eradication regimen in Greece.

Georgopoulos S, Papastergiou V, Xirouchakis E, Laudi F, Papantoniou N, Lisgos P, Spiliadi C, Fragou P, Skorda L, Karatapanis S.

Helicobacter. 2012 Feb;17(1):49-53. doi: 10.1111/j.1523-5378.2011.00911.x.

PMID:
22221616
3.

Clinical inquiry: Should you test for H pylori in patients with nonulcer dyspepsia?

Lanier JB, Wilder L.

J Fam Pract. 2011 Dec;60(12):767-8. Review. No abstract available.

PMID:
22163363
4.
5.

Ten-day sequential therapy of Helicobacter pylori infection in Thailand.

Sirimontaporn N, Thong-Ngam D, Tumwasorn S, Mahachai V.

Am J Gastroenterol. 2010 May;105(5):1071-5. doi: 10.1038/ajg.2009.708. Epub 2009 Dec 15.

PMID:
20010919
6.

[Gastroduodenal ulcer before and after Helicobacter pylori].

Bommelaer G, Stef A.

Gastroenterol Clin Biol. 2009 Aug-Sep;33(8-9):626-34. doi: 10.1016/j.gcb.2009.07.004. Epub 2009 Aug 13. French.

7.

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment.

Jafri NS, Hornung CA, Howden CW.

Ann Intern Med. 2008 Jun 17;148(12):923-31. Epub 2008 May 19. Erratum in: Ann Intern Med. 2008 Sep 16;149(6):439.

PMID:
18490667
8.

Levels of interleukin-18 are markedly increased in Helicobacter pylori-infected gastric mucosa among patients with specific IL18 genotypes.

Sakai K, Kita M, Sawai N, Shiomi S, Sumida Y, Kanemasa K, Mitsufuji S, Imanishi J, Yamaoka Y.

J Infect Dis. 2008 Jun 15;197(12):1752-61. doi: 10.1086/588196.

9.

Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.

Uygun A, Kadayifci A, Yesilova Z, Safali M, Ilgan S, Karaeren N.

Clin Ther. 2008 Mar;30(3):528-34. doi: 10.1016/j.clinthera.2008.03.009.

PMID:
18405790
10.

Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication.

Fuccio L, Minardi ME, Zagari RM, Grilli D, Magrini N, Bazzoli F.

Ann Intern Med. 2007 Oct 16;147(8):553-62.

PMID:
17938394
11.

Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.

Chung SJ, Lee DH, Kim N, Jung SH, Kim JW, Hwang JH, Park YS, Lee KH, Jung HC, Song IS.

Hepatogastroenterology. 2007 Jun;54(76):1293-6.

PMID:
17629092
12.

Practice patterns for managing Helicobacter pylori infection and upper gastrointestinal symptoms.

Howden CW, Blume SW, de Lissovoy G.

Am J Manag Care. 2007 Jan;13(1):37-44.

13.

Helicobacter pylori infection: treatment.

Belhoussine-Idrissi L, Boedeker EC.

Curr Opin Gastroenterol. 2002 Jan;18(1):26-33.

PMID:
17031226
14.

The treatment of peptic ulcer disease.

Louw JA, Marks IN.

Curr Opin Gastroenterol. 1999 Nov;15(6):497-503.

PMID:
17023996
15.

Efficacy of one-day quadruple therapy for H pylori infection in Chinese patients.

Huo XH, Chu JK, Yang XF, Wang J, Zhang LJ, Ma JC, Yu J.

World J Gastroenterol. 2006 May 21;12(19):3105-7.

16.

Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen.

Scaccianoce G, Hassan C, Panarese A, Piglionica D, Morini S, Zullo A.

Can J Gastroenterol. 2006 Feb;20(2):113-7.

17.

Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.

Calvet X, Ducons J, Bujanda L, Bory F, Montserrat A, Gisbert JP; Hp Study Group of the Asociación Española de Gastroenterología.

Am J Gastroenterol. 2005 Aug;100(8):1696-701.

PMID:
16086704
18.

[The influence of Helicobacter pylori eradication on oesophageal pH-metry and bilimetry results in patients with nonulcer dyspepsia].

Piotrowski W, Chojnacki J, Gil J, Walecka-Kapica E.

Pol Merkur Lekarski. 2004;17 Suppl 1:136-8. Polish.

PMID:
15603372
19.

Evaluation and management of nonulcer dyspepsia.

Dickerson LM, King DE.

Am Fam Physician. 2004 Jul 1;70(1):107-14. Review.

20.

Seven-day therapy for Helicobacter pylori in the United States.

Vakil N, Lanza F, Schwartz H, Barth J.

Aliment Pharmacol Ther. 2004 Jul 1;20(1):99-107.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk